Psychemedics Corp
NASDAQ:PMD
Psychemedics Corp
NASDAQ:PMD
Price:
2.67
USD
-1.84%
Market Closed
Market Cap:
$15.7m
Balance Sheet
Balance Sheet Decomposition
Psychemedics Corp
Psychemedics Corp
Balance Sheet Decomposition is not available for
Psychemedics Corp
Psychemedics Corp
Balance Sheet
Psychemedics Corp
Psychemedics Corp
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
4
|
3
|
4
|
8
|
4
|
7
|
3
|
2
|
5
|
2
|
|
| Cash Equivalents |
4
|
3
|
4
|
8
|
4
|
7
|
3
|
2
|
5
|
2
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
6
|
4
|
6
|
4
|
5
|
4
|
6
|
7
|
4
|
4
|
|
| Accounts Receivables |
4
|
4
|
6
|
4
|
5
|
4
|
3
|
4
|
4
|
4
|
|
| Other Receivables |
2
|
1
|
0
|
0
|
0
|
0
|
2
|
3
|
0
|
0
|
|
| Other Current Assets |
1
|
1
|
1
|
1
|
1
|
2
|
1
|
2
|
1
|
1
|
|
| Total Current Assets |
11
|
8
|
11
|
14
|
14
|
13
|
10
|
10
|
10
|
7
|
|
| PP&E Net |
13
|
13
|
13
|
12
|
10
|
14
|
14
|
10
|
7
|
5
|
|
| PP&E Gross |
13
|
13
|
13
|
12
|
10
|
14
|
14
|
10
|
7
|
5
|
|
| Accumulated Depreciation |
6
|
7
|
9
|
12
|
13
|
16
|
17
|
20
|
22
|
24
|
|
| Intangible Assets |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Assets |
24
N/A
|
22
-8%
|
25
+14%
|
27
+6%
|
25
-6%
|
28
+10%
|
24
-13%
|
22
-10%
|
19
-13%
|
12
-34%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
1
|
|
| Accrued Liabilities |
1
|
1
|
2
|
2
|
2
|
4
|
3
|
4
|
4
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
2
|
1
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
0
|
|
| Total Current Liabilities |
4
|
4
|
5
|
4
|
4
|
6
|
4
|
6
|
6
|
5
|
|
| Long-Term Debt |
5
|
4
|
2
|
2
|
1
|
2
|
3
|
1
|
0
|
0
|
|
| Deferred Income Tax |
3
|
3
|
3
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
2
|
4
|
3
|
2
|
1
|
|
| Total Liabilities |
11
N/A
|
10
-8%
|
9
-9%
|
8
-16%
|
6
-21%
|
11
+72%
|
11
+7%
|
9
-19%
|
8
-15%
|
6
-29%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
7
|
8
|
5
|
2
|
1
|
4
|
9
|
10
|
12
|
17
|
|
| Additional Paid In Capital |
29
|
30
|
31
|
31
|
32
|
32
|
33
|
33
|
34
|
35
|
|
| Treasury Stock |
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
2
|
|
| Total Equity |
13
N/A
|
12
-9%
|
16
+34%
|
19
+19%
|
19
+1%
|
17
-10%
|
13
-26%
|
12
-2%
|
11
-12%
|
7
-38%
|
|
| Total Liabilities & Equity |
24
N/A
|
22
-8%
|
25
+14%
|
27
+6%
|
25
-6%
|
28
+10%
|
24
-13%
|
22
-10%
|
19
-13%
|
12
-34%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
5
|
5
|
5
|
5
|
6
|
6
|
6
|
6
|
6
|
6
|
|
Switch to:
Switch to:
See Also
Discover More
